Calamos Advisors LLC - IRADIMED CORP ownership

IRADIMED CORP's ticker is IRMD and the CUSIP is 46266A109. A total of 90 filers reported holding IRADIMED CORP in Q1 2023. The put-call ratio across all filers is - and the average weighting 0.2%.

Quarter-by-quarter ownership
Calamos Advisors LLC ownership history of IRADIMED CORP
ValueSharesWeighting
Q3 2023$1,594,525
+1.4%
35,937
+9.1%
0.01%0.0%
Q2 2023$1,572,412
+28.0%
32,937
+5.5%
0.01%
+33.3%
Q1 2023$1,228,074
+243.0%
31,209
+146.6%
0.01%
+200.0%
Q4 2022$358,067
-83.6%
12,657
-82.6%
0.00%
-80.0%
Q3 2022$2,187,000
-19.9%
72,762
-9.6%
0.01%
-16.7%
Q2 2022$2,731,000
-30.4%
80,467
-8.1%
0.01%
-20.0%
Q1 2022$3,926,000
+21.8%
87,566
+25.6%
0.02%
+25.0%
Q4 2021$3,223,000
+1023.0%
69,744
+494.1%
0.01%
+500.0%
Q4 2018$287,000
-34.2%
11,7400.0%0.00%0.0%
Q3 2018$436,00011,7400.00%
Other shareholders
IRADIMED CORP shareholders Q1 2023
NameSharesValueWeighting ↓
Nine Ten Capital Management LLC 783,066$30,814,0005.13%
Soleus Capital Management, L.P. 773,694$30,444,8593.15%
RK Capital 335,400$13,197,9902.90%
Capital Impact Advisors, LLC 19,390$762,9970.94%
Ranger Investment Management 205,692$8,093,9800.54%
Bares Capital Management 317,000$12,473,9500.44%
Hillsdale Investment Management Inc. 109,100$4,293,0850.37%
CORNERCAP INVESTMENT COUNSEL INC 37,007$1,456,2250.26%
Riverwater Partners LLC 6,234$245,3080.22%
RICE HALL JAMES & ASSOCIATES, LLC 72,271$2,843,8640.16%
View complete list of IRADIMED CORP shareholders